Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
about
KASL clinical practice guidelines: management of chronic hepatitis BProphylaxis against Recurrence in Liver Transplantation Patients with Hepatitis B Virus: What is New?Molecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceHepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcomeApplication of nucleoside analogues to liver transplant recipients with hepatitis BOne year of hepatitis B immunoglobulin plus tenofovir therapy is safe and effective in preventing recurrent hepatitis B post-liver transplantationContradictory immune response in post liver transplantation hepatitis B and C.Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B.High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.Hepatitis B and C in liver transplantation: new strategies to combat the enemies.Safe and cost-effective control of post-transplantation recurrence of hepatitis B.HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation.Recent advances in prevention of hepatitis B recurrence after liver transplantation.Management of hepatitis B virus infection after liver transplantation.Low incidence of acute rejection in hepatitis B virus positive liver transplant recipients and the impact of hepatitis B immunoglobulin.A 6-month mixed-effect pharmacokinetic model for post-transplant intravenous anti-hepatitis B immunoglobulin prophylaxis.Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.Management of chronic hepatitis B in severe liver disease.Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative.Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation.Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.
P2860
Q26752475-16FD7994-4623-4DBA-806A-F62EB485B390Q26781880-39A23E87-48A6-4769-A35E-CDE271388F4EQ26799246-60A21AEA-06B5-4873-9419-926F2302A6EEQ26859121-7CF0E13F-780A-4271-9AB4-FD7199477147Q26859796-1C8B4982-07C7-456C-B908-689C9502E262Q33810155-B4AFEEA6-95AA-4FB0-B7EF-C1C31CB04F17Q34152074-3A9174B2-3892-46EC-BB54-6D606E604BADQ37217853-E5A57967-68A7-47E8-B26F-9B5F5886999DQ38058545-68E91731-8D2E-4903-A7FF-4A5D18CE223DQ38067343-60B19C3B-A58D-4ED6-97CB-D6FA58DBADC6Q38218260-E638C96C-5DC7-4173-A948-BF8558C1D19BQ38218762-0EC034D5-02E8-4356-84CD-3C084B243B59Q38333875-DD54D704-83AB-4A7D-8EDF-15DC7C7C860CQ38635614-0629252C-1948-48F0-B220-5D1E1653837BQ40774233-EF34DC24-3F10-44A0-B4AC-246D3825CBE4Q41037062-3DB89E99-AE4C-4D40-A8CC-EC1780556C75Q41062056-DFDAA81F-CD6A-4D6C-AB70-3C1BF8CD4CF3Q41619231-EEE33EC1-36EF-46C7-9578-77471351CF55Q41755402-7245497F-485C-4FF7-A265-AC3ED58564A1Q42144316-E1E6DB35-A020-409F-81AD-72DFEDD17040Q42213645-15EA51EF-F6B1-4601-B8E4-620FA7860C05Q42263202-303CD76E-162C-47FB-8FF0-056FCB045769Q44966178-6F1F4BC1-465F-4775-9186-EE876569B431Q52620441-AEB6077C-0126-4B31-92FD-0DD19554A6A8
P2860
Substitution of tenofovir/emtricitabine for Hepatitis B immune globulin prevents recurrence of Hepatitis B after liver transplantation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Substitution of tenofovir/emtr ...... B after liver transplantation.
@en
Substitution of tenofovir/emtr ...... B after liver transplantation.
@nl
type
label
Substitution of tenofovir/emtr ...... B after liver transplantation.
@en
Substitution of tenofovir/emtr ...... B after liver transplantation.
@nl
prefLabel
Substitution of tenofovir/emtr ...... B after liver transplantation.
@en
Substitution of tenofovir/emtr ...... B after liver transplantation.
@nl
P2093
P2860
P1433
P1476
Substitution of tenofovir/emtr ...... B after liver transplantation.
@en
P2093
Adrian H Cotterell
Arun J Sanyal
Marc P Posner
Melissa Kimmel
Mitchell L Shiffman
Puneet Puri
R Todd Stravitz
Richard K Sterling
Robert A Fisher
Velimir A Luketic
P2860
P304
P356
10.1111/J.1478-3231.2012.02770.X
P577
2012-02-21T00:00:00Z